207 related articles for article (PubMed ID: 12054798)
21. Angiostatin fragments in urine from patients with malignant disease.
Sten-Linder M; Linder C; Strander H; Munck-Wikland E; Wersäll P; Linder S; Wiman B
Anticancer Res; 1999; 19(4C):3409-14. PubMed ID: 10629628
[TBL] [Abstract][Full Text] [Related]
22. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
[TBL] [Abstract][Full Text] [Related]
23. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).
Lijnen HR; Ugwu F; Bini A; Collen D
Biochemistry; 1998 Apr; 37(14):4699-702. PubMed ID: 9548733
[TBL] [Abstract][Full Text] [Related]
24. Human glioma cell BT325 expresses a proteinase that converts human plasminogen to kringle 1-5-containing fragments.
Li F; Yang J; Liu X; He P; Ji S; Wang J; Han J; Chen N; Yao L
Biochem Biophys Res Commun; 2000 Nov; 278(3):821-5. PubMed ID: 11095991
[TBL] [Abstract][Full Text] [Related]
25. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
[TBL] [Abstract][Full Text] [Related]
26. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
[TBL] [Abstract][Full Text] [Related]
27. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles.
An SS; Carreño C; Marti DN; Schaller J; Albericio F; Llinas M
Protein Sci; 1998 Sep; 7(9):1960-9. PubMed ID: 9761476
[TBL] [Abstract][Full Text] [Related]
28. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
[TBL] [Abstract][Full Text] [Related]
29. What the structure of angiostatin may tell us about its mechanism of action.
Geiger JH; Cnudde SE
J Thromb Haemost; 2004 Jan; 2(1):23-34. PubMed ID: 14717962
[TBL] [Abstract][Full Text] [Related]
30. Kringle-kringle interactions in multimer kringle structures.
Padmanabhan K; Wu TP; Ravichandran KG; Tulinsky A
Protein Sci; 1994 Jun; 3(6):898-910. PubMed ID: 8069221
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
32. Kringle 1 of human hepatocyte growth factor inhibits bovine aortic endothelial cell proliferation stimulated by basic fibroblast growth factor and causes cell apoptosis.
Xin L; Xu R; Zhang Q; Li TP; Gan RB
Biochem Biophys Res Commun; 2000 Oct; 277(1):186-90. PubMed ID: 11027661
[TBL] [Abstract][Full Text] [Related]
33. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
34. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
[TBL] [Abstract][Full Text] [Related]
35. The angiogenesis inhibitor protease-activated kringles 1-5 reduces the severity of murine collagen-induced arthritis.
Sumariwalla PF; Cao Y; Wu HL; Feldmann M; Paleolog EM
Arthritis Res Ther; 2003; 5(1):R32-9. PubMed ID: 12716451
[TBL] [Abstract][Full Text] [Related]
36. Angiostatin-like molecules are generated by snake venom metalloproteinases.
Ho PL; Serrano SM; Chudzinski-Tavassi AM; Moura da Silva AM; Mentele R; Caldas C; Oliva ML; Batista IF; Oliveira ML
Biochem Biophys Res Commun; 2002 Jun; 294(4):879-85. PubMed ID: 12061789
[TBL] [Abstract][Full Text] [Related]
37. Angiostatin.
Cao Y; Xue L
Semin Thromb Hemost; 2004 Feb; 30(1):83-93. PubMed ID: 15034800
[TBL] [Abstract][Full Text] [Related]
38. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).
Goretzki L; Lombardo CR; Stallcup WB
J Biol Chem; 2000 Sep; 275(37):28625-33. PubMed ID: 10889192
[TBL] [Abstract][Full Text] [Related]
39. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
Kim HK; Joe YA
Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
[TBL] [Abstract][Full Text] [Related]
40. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9).
Patterson BC; Sang QA
J Biol Chem; 1997 Nov; 272(46):28823-5. PubMed ID: 9360944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]